These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31842318)

  • 1. Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe.
    Wadowski PP; Giurgea GA; Schlager O; Luf A; Gremmel T; Hobl EL; Unterhumer S; Löffler-Stastka H; Koppensteiner R
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31842318
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
    Ameline A; Farrugia A; Raul JS; Kintz P
    Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
    Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
    J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.
    Schetz D; Schetz A; Kocić I
    Biomed Pharmacother; 2022 Feb; 146():112295. PubMed ID: 34980551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
    Halberstadt AL; Geyer MA
    Neuropharmacology; 2014 Feb; 77():200-7. PubMed ID: 24012658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
    Kamińska K; Świt P; Malek K
    J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I-NBOMe.
    Garrido E; Alfonso M; Díaz de Greñu B; Lozano-Torres B; Parra M; Gaviña P; Marcos MD; Martínez-Máñez R; Sancenón F
    Chemistry; 2020 Mar; 26(13):2813-2816. PubMed ID: 31943443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
    Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
    J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
    Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
    J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
    Halberstadt AL
    Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
    Nisbet LA; Venson R; Wylie FM; Scott KS
    J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.
    Hermanns-Clausen M; Angerer V; Kithinji J; Grumann C; Auwärter V
    Clin Toxicol (Phila); 2017 Sep; 55(8):922-924. PubMed ID: 28471280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats.
    Herian M; Wojtas A; Kamińska K; Świt P; Wach A; Gołembiowska K
    Neurotox Res; 2019 Jul; 36(1):91-100. PubMed ID: 30989482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe.
    Herian M; Skawski M; Wojtas A; Sobocińska MK; Noworyta K; Gołembiowska K
    Psychopharmacology (Berl); 2021 Aug; 238(8):2349-2364. PubMed ID: 34032876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.
    Lowe LM; Peterson BL; Couper FJ
    J Anal Toxicol; 2015 Oct; 39(8):668-71. PubMed ID: 26378143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological findings in 2 cases of fatal 25I-NBOMe toxicity.
    Walterscheid JP; Phillips GT; Lopez AE; Gonsoulin ML; Chen HH; Sanchez LA
    Am J Forensic Med Pathol; 2014 Mar; 35(1):20-5. PubMed ID: 24457586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25I-NBOMe related death in Australia: a case report.
    Kueppers VB; Cooke CT
    Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.
    Suzuki J; Dekker MA; Valenti ES; Arbelo Cruz FA; Correa AM; Poklis JL; Poklis A
    Psychosomatics; 2015; 56(2):129-39. PubMed ID: 25659919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.